Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?

To: ColtonGang who wrote (172388)	8/17/2001 4:01:38 PM
From: DMaA	Read Replies (1) \| Respond to of 769667

You might have a point if the democrats didn't control the senate. Jeffords did the democrats no favor.

To: ColtonGang who wrote (172388)	8/17/2001 4:09:12 PM
From: DMaA	Read Replies (1) \| Respond to of 769667

Hopes for a summer rally were dashed when Daschle started promising a democrat tax increase.

To: ColtonGang who wrote (172388)	8/17/2001 4:34:05 PM
From: Thomas A Watson	Read Replies (2) \| Respond to of 769667

Yes it looks like another tax cut to move more money into the economy is needed. But the dem dems showing how not to be nice and proposing raising taxes will not be very helpful. tom watson tosiwmee

To: ColtonGang who wrote (172388)	8/18/2001 8:46:18 AM
From: Neocon	Read Replies (2) \| Respond to of 769667

If Daschle would shut up, it would help......

To: ColtonGang who wrote (172388)	8/18/2001 9:34:36 AM
From: jlallen	Read Replies (3) \| Respond to of 769667

Non-Embryonic Stem Cell Research Shows Promise Fox News Friday, August 17, 2001 By Kelley O. Beaucar Recent studies on the flexibility and efficacy of non-embryonic stem cell research have bolstered scientists and ethicists hoping to circumvent the ethical and moral concerns surrounding the destruction of embryos required for embryonic stem cell research. Those ethical concerns reached a climax last week when President George W. Bush announced that he would approve federal funding for testing on embryonic stem cell lines, limited to existing lines derived from destroyed embryos where, he said, "the life and death decision" had already been made. Less attention has been paid to research on non-embryonic stem cells. This research does not carry the same ethical questions because the cells can be derived without destroying embryos. Most scientists had felt, however, that these adult stem cells were not as flexible as those derived from embryos. A study published this week in the journal Nature Cell Biology by McGill University's Montreal Neurological Institute offers hope that adult stem cells may eventually be just as effective as embryonic stem cell research in treating brain disorders, replacing tissue, and finding cures for disease. According to the research, stem cells derived from adult human skin tissue have the capability of reforming as muscle, fat and complex brain cells. A spokesman for the McGill scientists called their research a "breakthrough." She said that, until now, cells taken from skin or marrow have proven less versatile than embryonic stem cells. "Embryonic stem cells are on one end and they can become anything. Adult cells are a little more restricted," said Sandra McPherson. But "these stem cells," she said, "seem to be more in-between, [in that] they are closer to embryonic because they seem to become three or four different cells." And she indicated that this could be just the beginning. "One of their next steps is to find out just how many other types these cells can differentiate into," she said. Another study, from the April issue of the scientific journal Tissue Engineering, reported that stem cells derived from fat retrieved from liposuction procedures have been transformed into bone, muscle, cartilage, and mature fat cells Michael Novak, a theologian with the American Enterprise Institute in Washington, calls it "a blessing" that adult stem cell research is moving forward strongly and would like to see more attention paid to the research. "It would be a great blessing if you could achieve the same ends with this [adult cell] research," Novak said. "The president himself referred to such therapeutic breakthroughs that had been made in stem cell analysis. There was also some indication from the president that he would give a lot of attention to the research." Novak and others opposed to embryonic research hope that the promise of adult stem cell research may lead scientists to focus their energies there and not on the controversial research that requires the destruction of embryos. Dr. Richard Burt, the head of the Immune Therapy and Auto-Immune Disease Division at the Northwestern University Medical School in Chicago, agreed that advances in adult stem cell research could help erase the thorny ethical problem. "It would remove all of the ethical and practical issues that you have with testing on embryonic stem cells - that's one of the reasons I work with adult stem cells," said Burt, who has been studying blood and marrow stem cell uses for 14 years. Burt applauded Bush's cautious approach to federal funding of stem cell research. "I can see both sides of the issue," he said. The White House declined comment on the McGill study, but the National Institutes of Health downplayed the findings and asserted that embryonic cells still provide the best chances for successful research. Spokesman Marc Stern said NIH has spent over $250 million on both adult and embryonic stem cell research. "There is much more versatility," he said of the embryonic stem cells. "Our belief is embryonic stem cells will be better," he said, explaining that not only can those cells reform into any part of the human body, their reproduction is limitless. The same cannot yet be said of adult cells, he said.